BR0210650A - Tablete, e, uso do mesmo - Google Patents
Tablete, e, uso do mesmoInfo
- Publication number
- BR0210650A BR0210650A BR0210650-7A BR0210650A BR0210650A BR 0210650 A BR0210650 A BR 0210650A BR 0210650 A BR0210650 A BR 0210650A BR 0210650 A BR0210650 A BR 0210650A
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- relates
- combinations
- methods
- present
- Prior art date
Links
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30125001P | 2001-06-28 | 2001-06-28 | |
| EP01115807 | 2001-06-28 | ||
| PCT/EP2002/006342 WO2003002098A1 (en) | 2001-06-28 | 2002-06-10 | Tablet comprising cetirizine and pseudoephedrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210650A true BR0210650A (pt) | 2004-10-05 |
Family
ID=56290291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0210650-7A BR0210650A (pt) | 2001-06-28 | 2002-06-10 | Tablete, e, uso do mesmo |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1404304B1 (https=) |
| JP (1) | JP4041460B2 (https=) |
| KR (1) | KR100926410B1 (https=) |
| CN (1) | CN100490809C (https=) |
| AT (1) | ATE432068T1 (https=) |
| AU (1) | AU2002345024B2 (https=) |
| BR (1) | BR0210650A (https=) |
| CA (1) | CA2451519C (https=) |
| CZ (1) | CZ20033454A3 (https=) |
| DK (1) | DK1404304T3 (https=) |
| EE (1) | EE05357B1 (https=) |
| ES (1) | ES2324769T3 (https=) |
| HU (1) | HU229803B1 (https=) |
| MX (1) | MXPA03010430A (https=) |
| NZ (1) | NZ530289A (https=) |
| PL (1) | PL206069B1 (https=) |
| PT (1) | PT1404304E (https=) |
| RO (1) | RO122476B1 (https=) |
| RU (1) | RU2286784C2 (https=) |
| SI (1) | SI1404304T1 (https=) |
| SK (1) | SK287645B6 (https=) |
| WO (1) | WO2003002098A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7014867B2 (en) * | 2001-06-28 | 2006-03-21 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| WO2007141743A2 (en) * | 2006-06-06 | 2007-12-13 | Ranbaxy Laboratories Limited | A tablet dosage form comprising cetirizine and pseudoephedrine |
| US9408816B2 (en) * | 2006-12-26 | 2016-08-09 | Pharmacyclics Llc | Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
| CN105381524A (zh) | 2010-01-05 | 2016-03-09 | 微剂量治疗技术公司 | 吸入设备和方法 |
| KR101193495B1 (ko) * | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
| KR20130050952A (ko) * | 2010-06-16 | 2013-05-16 | 브루스 챈들러 메이 | 인플루엔자, 감기 및 염증의 치료에서 레보세티리진 및 몬테루카스트의 용도 |
| CN102302497A (zh) * | 2011-05-18 | 2012-01-04 | 天圣制药集团股份有限公司 | 一种治疗过敏性鼻炎的制剂及其制备方法 |
| KR20130009553A (ko) | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제 |
| JP6330118B2 (ja) | 2011-09-13 | 2018-05-30 | ファーマサイクリックス エルエルシー | ベンダムスチンと組み合わせたヒストンデアセチラーゼ阻害剤の製剤とその使用 |
| KR101372324B1 (ko) * | 2012-02-09 | 2014-03-13 | 동국대학교 경주캠퍼스 산학협력단 | 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물 |
| ES2654093T3 (es) | 2013-03-13 | 2018-02-12 | Inflammatory Response Research, Inc. | Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes |
| CA2901413A1 (en) | 2013-03-13 | 2014-10-09 | Bruce Chandler May | Use of levocetirizine and montelukast in the treatment of vasculitis |
| RU2672871C2 (ru) | 2013-03-13 | 2018-11-20 | Инфламматори Респонс Ресёрч, Инк. | Применение левоцетиризина и монтелукаста при лечении травматических повреждений |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| WO2016140630A1 (en) | 2015-03-05 | 2016-09-09 | PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. | An effervescent composition comprising levocetirizine and pseudoephedrine |
| EP4099977A1 (en) * | 2020-02-03 | 2022-12-14 | Johnson & Johnson Consumer Inc. | A single layer chewable tablet comprising cetirizine |
| EP4153178A4 (en) | 2020-05-19 | 2024-06-05 | Irr, Inc. | Levocetirizine and montelukast in the treatment of sepsis and symptoms thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469009B1 (en) * | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
| EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
-
2002
- 2002-06-10 AT AT02743173T patent/ATE432068T1/de active
- 2002-06-10 SI SI200230844T patent/SI1404304T1/sl unknown
- 2002-06-10 WO PCT/EP2002/006342 patent/WO2003002098A1/en not_active Ceased
- 2002-06-10 SK SK1550-2003A patent/SK287645B6/sk not_active IP Right Cessation
- 2002-06-10 RO ROA200301062A patent/RO122476B1/ro unknown
- 2002-06-10 PT PT02743173T patent/PT1404304E/pt unknown
- 2002-06-10 EE EEP200400005A patent/EE05357B1/xx unknown
- 2002-06-10 CA CA002451519A patent/CA2451519C/en not_active Expired - Lifetime
- 2002-06-10 KR KR1020037017054A patent/KR100926410B1/ko not_active Expired - Lifetime
- 2002-06-10 DK DK02743173T patent/DK1404304T3/da active
- 2002-06-10 CZ CZ20033454A patent/CZ20033454A3/cs unknown
- 2002-06-10 HU HU0400386A patent/HU229803B1/hu unknown
- 2002-06-10 JP JP2003508337A patent/JP4041460B2/ja not_active Expired - Fee Related
- 2002-06-10 MX MXPA03010430A patent/MXPA03010430A/es active IP Right Grant
- 2002-06-10 RU RU2004101231/15A patent/RU2286784C2/ru active
- 2002-06-10 CN CNB02812975XA patent/CN100490809C/zh not_active Expired - Lifetime
- 2002-06-10 ES ES02743173T patent/ES2324769T3/es not_active Expired - Lifetime
- 2002-06-10 BR BR0210650-7A patent/BR0210650A/pt not_active Application Discontinuation
- 2002-06-10 AU AU2002345024A patent/AU2002345024B2/en not_active Ceased
- 2002-06-10 NZ NZ530289A patent/NZ530289A/en unknown
- 2002-06-10 PL PL366800A patent/PL206069B1/pl unknown
- 2002-06-10 EP EP02743173A patent/EP1404304B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| RU2286784C2 (ru) | 2006-11-10 |
| CZ20033454A3 (cs) | 2004-08-18 |
| WO2003002098A1 (en) | 2003-01-09 |
| CA2451519C (en) | 2007-11-06 |
| ES2324769T3 (es) | 2009-08-14 |
| PL366800A1 (en) | 2005-02-07 |
| JP4041460B2 (ja) | 2008-01-30 |
| SK15502003A3 (sk) | 2004-05-04 |
| ATE432068T1 (de) | 2009-06-15 |
| HUP0400386A2 (hu) | 2004-08-30 |
| CA2451519A1 (en) | 2003-01-09 |
| EE05357B1 (et) | 2010-12-15 |
| AU2002345024B2 (en) | 2006-09-07 |
| PT1404304E (pt) | 2009-06-26 |
| JP2004536829A (ja) | 2004-12-09 |
| RU2004101231A (ru) | 2005-04-20 |
| KR100926410B1 (ko) | 2009-11-12 |
| NZ530289A (en) | 2004-11-26 |
| CN100490809C (zh) | 2009-05-27 |
| HUP0400386A3 (en) | 2006-02-28 |
| DK1404304T3 (da) | 2009-07-13 |
| CN1520285A (zh) | 2004-08-11 |
| KR20040007756A (ko) | 2004-01-24 |
| PL206069B1 (pl) | 2010-06-30 |
| RO122476B1 (ro) | 2009-07-30 |
| SK287645B6 (sk) | 2011-05-06 |
| SI1404304T1 (sl) | 2009-10-31 |
| EE200400005A (et) | 2004-02-16 |
| EP1404304B1 (en) | 2009-05-27 |
| MXPA03010430A (es) | 2004-12-06 |
| EP1404304A1 (en) | 2004-04-07 |
| HU229803B1 (en) | 2014-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0210650A (pt) | Tablete, e, uso do mesmo | |
| PT1605956E (pt) | Administração de capsaicinóides para o tratamento da osteoartrite | |
| PT1339399E (pt) | Combinacoes de drogas (e.g., clorpromazina e pentamidina) para o tratamento de desordens neoplasicas | |
| BRPI0410503B8 (pt) | composição tópica e uso da composição | |
| EA200400481A1 (ru) | Применение флибансерина для лечения половых расстройств | |
| HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
| DOP2002000429A (es) | Imidazotriazinas | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| BRPI0407662A (pt) | derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas | |
| BR0209812A (pt) | Uso de osteopontina para o tratamento e/ou a prevenção de doenças neurológicas | |
| UY27993A1 (es) | Derivados de 4-pirrolidino-fenil-bencil eter | |
| ECSP034518A (es) | Nuevos retinoides para el tratamiento de enfisema | |
| CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
| BRPI0408863A (pt) | composto, composição farmacêutica, método para tratar doenças, e, uso de um composto. | |
| BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
| BRPI0411864A (pt) | combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| PT1355906E (pt) | Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas | |
| CY1110368T1 (el) | Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη | |
| BRPI0607684A2 (pt) | composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida | |
| EA200500774A1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
| BR0313230A (pt) | Uso de carboxamidas para o tratamento de tinido | |
| DE60322577D1 (de) | Tablette enthaltend efletirizin und pseudoephedrin | |
| JO2666B1 (en) | Use of Agomelatine in obtaining medicaments intented for the treatment of Bipolar disorders | |
| BRPI0408743A (pt) | formulações compreendendo tolterodina e cacau em pó e sua utilização | |
| EA200500538A1 (ru) | Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: A61K 31/137, A61K 31/495, A61K 47/36, A61P 47/38, A61K 9/20, A61K 9/24, A61K 9/26, A61P 11/00, A61P 11/02, A61P 27/02, A61P 37/08 Ipc: A61K 9/20 (2011.01), A61K 31/495 (2011.01) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |